Biotechnology Biogen/Eisai’s Popular Alzheimer’s Drug Leqembi Is Seeing Slow Adoption – Here’s Why – Biogen (NASDAQ:BIIB) Read more
Biotechnology European Medicines Agency Delays Approval Decision For Biogen-Eisai Partnered Alzheimer’s Drug Lecanemab Why Is Biogen Stock Falling Friday? – Biogen (NASDAQ:BIIB) Read more
Biotechnology What’s Going On With Eli Lilly And Biogen Stocks On Friday? – Eli Lilly and Co (NYSE:LLY) Read more
Biotechnology Biogen Could Engage In $1B-$2B Deals To Fill Revenue Shortfall Gaps, Analyst Says – Biogen (NASDAQ:BIIB) Read more
